Elevance Health, Inc.’s Stock Price Soars to $525.19, Marking a Robust 3.19% Increase

Elevance Health, Inc. (ELV)

525.19 USD +16.22 (+3.19%) Volume: 2.59M

Elevance Health, Inc.’s stock price has soared to 525.19 USD, marking a positive trading session change of +3.19% with a robust trading volume of 2.59M. With an impressive year-to-date increase of +11.37%, ELV’s stock performance continues to show strong growth potential for investors.

Latest developments on Elevance Health, Inc.

Elevance Health, Inc. (NYSE:ELV) has been in the spotlight following its Q1 2024 earnings report. Despite a 21% drop in Medicaid enrolment, the company reported a $2.2 billion profit, beating estimates, and lifting annual guidance. This success has been attributed to higher premiums keeping costs under control and commercial gains offsetting Medicaid and Medicare losses. Amidst industry cyberattack concerns, Elevance also offered a glimpse into the impacts of the Change cyberattack. These developments have led to a surge in ELV’s stock price, hitting a new 52-week high at $533.56.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma